Table 5.
A summary of the epidemiologic assessments and causality conclusions for hepatitis A vaccine
Type vaccine | Adverse event | Epidemiologic assessment | Studies contributing to epidemiologic assessment | Causality conclusion |
---|---|---|---|---|
Hepatitis A vaccine | Transverse myelitis | Insufficient | None | Inadequate |
MS | Insufficient | None | Inadequate | |
Guillain–Barré syndrome | Insufficient | None | Inadequate | |
Chronic inflammatory disseminated polyneuropathy | Insufficient | None | Inadequate | |
Autoimmune hepatitis | insufficient | None | Inadequate |